TRAF6 and neoplasm: Moreover, miR-146a, which targets TRAF6 and IRAK1 mRNA for degradation, was shown to act as a tumor suppressor in the hematopoietic compartment and can control myeloproliferation in the spleen and BM through negative regulation of NF-kB [79], hence further linking chronic inflammation through MyD88 in MPNs.